FDA Accuses Cadila Of Major Violations At India Plant
The U.S. Food and Drug Administration revealed Tuesday that it had warned drugmaker Cadila Healthcare Ltd. about significant manufacturing violations at a plant in India....To view the full article, register now.
Already a subscriber? Click here to view full article